Nada Jabado
McGill University
H-index: 102
North America-Canada
Top articles of Nada Jabado
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma | Modern Pathology | Ricardo Santiago Gomez Ahmed El Mouatani Filipe Fideles Duarte-Andrade Thais dos Santos Fontes Pereira Letícia Martins Guimarães | 2024/2/1 |
CD155 regulates cell growth and immune evasion in diffuse midline glioma | Cancer Research | Theophilos Tzaridis Tanja Eisemann Augusto Faria Andrade Jennifer L Hope Oren Becher | 2024/3/22 |
Bevacizumab in the Treatment of Refractory Brain Edema in High-grade Glioma | Journal of Pediatric Hematology/Oncology | Aysha K Alsahlawi Claudie Michaud-Couture Alexandre Lachance Samuel Bergeron-Gravel Mélanie Létourneau | 2024/1/1 |
Recurrent primary intracranial sarcoma, DICER1-mutant in a pediatric patient with DICER1 syndrome: the importance of molecular testing | Child's Nervous System | Alexandre Lachance Evan Dimentberg Sidong Huang Samuel Bergeron-Gravel Éric Bouffet | 2024/3/13 |
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma | Cancer & Metabolism | Erik R Peterson Peter Sajjakulnukit Andrew J Scott Caleb Heaslip Anthony Andren | 2024/4/9 |
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial | Nature medicine | Lindsay B Kilburn Dong-Anh Khuong-Quang Jordan R Hansford Daniel Landi Jasper van der Lugt | 2024/1 |
Impact of trametinib on the neuropsychological profile of NF1 patients | Journal of Neuro-Oncology | Eve Lalancette Édith Cantin Marie-Ève Routhier Chantal Mailloux Marie-Claude Bertrand | 2024/3/5 |
The Virtual Child | Cancer Discovery | Richard J Gilbertson Sam Behjati Anna-Lisa Böttcher Marianne E Bronner Matthew Burridge | 2024/4/4 |
Abstract B045: Adaptive purine metabolism drives radiation therapy resistance in H3K27M-diffuse midline glioma | Cancer Research | Erik R Peterson Peter Sajjakulnukit Andrew Scott Caleb Heaslip Anthony Andren | 2024/3/4 |
Advances in pediatric gliomas: from molecular characterization to personalized treatments | Sayanthen Sathyakumar Matthew Martinez Sébastien Perreault Geneviève Legault Eric Bouffet | 2024/4/1 | |
Abstract B035: A compendium of syngeneic, transplantable pediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities | Cancer Research | Michael McNicholas Antonella De Cola Zahedeh Bashardanesh Amelia Foss Cameron Lloyd | 2024/3/4 |
262 The BRAF V600E Mutation and Tumor Cells Are Frequently Seen in Seemingly Normal Brain Parenchyma Beyond Ganglioglioma Tumor Borders: Implications for Seizure and Tumor Control | Neurosurgery | Rakan Farouk Y Bokhari Jason Karamchandani Nada Jabado Marie-Christine Guiot Roy WR Dudley | 2024/4/1 |
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047) | Neuro-oncology | Michelle Monje Tabitha Cooney John Glod Jie Huang Cody J Peer | 2023/12/1 |
Using comprehensive genomic and functional analyses for resolving genotype–phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study | Human Genetics | Dima Hamideh Anirban Das Vanessa Bianchi Jiil Chung Logine Negm | 2023/4 |
DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16 | Neuro-Oncology | Akanksha Chilukuri Matthew Halbert Brian Golbourn Srinidhi Varadharajan Brian Krug | 2023/6/1 |
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas | Nature Communications | Romain Sigaud Thomas K Albert Caroline Hess Thomas Hielscher Nadine Winkler | 2023/7/27 |
Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes | Journal of medical genetics | Robyn Hebert Noelle Cullinan Linlea Armstrong Katherine A Blood Josee Brossard | 2023/12/1 |
SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease | Molecular Cell | Carol CL Chen Augusto Faria Andrade Nada Jabado | 2023/1/19 |
Oncohistones in brain tumors: the soil and seed | Augusto Faria Andrade Carol CL Chen Nada Jabado | 2023/3/16 | |
DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS | Neuro-Oncology | Jessica Tsai Paloma Cejas Marissa Coppola Dayle Wang Smruti Patel | 2023/6/1 |
Co-Authors
